Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $1.66B.
ENTERPRISE VALUE (EV)
$1.66B
Xeris Biopharma Holdings, Inc.
Market Cap
$1.73B
Enterprise Value (EV)
$1.66B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Xeris Biopharma Holdings, Inc. (XERS) | $1.73B | $1.66B |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.74B | $1.37B |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.75B | $1.71B |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.71B | $3.78B |
| Personalis, Inc. (PSNL)vs › | $1.71B | $1.65B |
| Surgery Partners, Inc. (SGRY)vs › | $1.76B | $5.57B |
| Novocure Ltd (NVCR)vs › | $1.77B | $1.91B |
| Zenas BioPharma, Inc. (ZBIO)vs › | $1.69B | $1.89B |
| Absci Corporation (ABSI)vs › | $1.78B | $1.68B |
| Xencor, Inc. (XNCR)vs › | $1.79B | $1.81B |
Market Cap
$1.73B
Total Debt
$37.76M
Cash
$111.04M
Enterprise Value
$1.66B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
